BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 31164151)

  • 1. Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation.
    Wang JC; Li GY; Wang B; Han SX; Sun X; Jiang YN; Shen YW; Zhou C; Feng J; Lu SY; Liu JL; Wang MD; Liu PJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):235. PubMed ID: 31164151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIM-homeobox gene 2 promotes tumor growth and metastasis by inducing autocrine and paracrine PDGF-B signaling.
    Kuzmanov A; Hopfer U; Marti P; Meyer-Schaller N; Yilmaz M; Christofori G
    Mol Oncol; 2014 Mar; 8(2):401-16. PubMed ID: 24423492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
    Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis.
    Hosaka K; Yang Y; Seki T; Nakamura M; Andersson P; Rouhi P; Yang X; Jensen L; Lim S; Feng N; Xue Y; Li X; Larsson O; Ohhashi T; Cao Y
    Nat Commun; 2013; 4():2129. PubMed ID: 23831851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iPSC-Derived Hereditary Breast Cancer Model Reveals the
    Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin.
    Shen Y; Li S; Wang X; Wang M; Tian Q; Yang J; Wang J; Wang B; Liu P; Yang J
    J Exp Clin Cancer Res; 2019 Oct; 38(1):427. PubMed ID: 31656203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.
    Malavaki CJ; Roussidis AE; Gialeli C; Kletsas D; Tsegenidis T; Theocharis AD; Tzanakakis GN; Karamanos NK
    FEBS J; 2013 May; 280(10):2477-89. PubMed ID: 23374223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
    Wang Z; Lv J; Zhang T
    Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crocin and Metformin suppress metastatic breast cancer progression via VEGF and MMP9 downregulations: in vitro and in vivo studies.
    Farahi A; Abedini MR; Javdani H; Arzi L; Chamani E; Farhoudi R; Talebloo N; Hoshyar R
    Mol Cell Biochem; 2021 Sep; 476(9):3341-3351. PubMed ID: 33929675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxic effects of metformin on endothelial cells and angiogenesis.
    Dallaglio K; Bruno A; Cantelmo AR; Esposito AI; Ruggiero L; Orecchioni S; Calleri A; Bertolini F; Pfeffer U; Noonan DM; Albini A
    Carcinogenesis; 2014 May; 35(5):1055-66. PubMed ID: 24419232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis.
    Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P
    Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of platelet-derived growth factor-B on renal cell carcinoma growth and progression.
    Wang W; Qi L; Tan M; Zhang Z; Du J; Wei X; Yao X
    Urol Oncol; 2015 Apr; 33(4):168.e17-27. PubMed ID: 25766258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
    Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
    J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer.
    Athreya AP; Kalari KR; Cairns J; Gaglio AJ; Wills QF; Niu N; Weinshilboum R; Iyer RK; Wang L
    Oncotarget; 2017 Apr; 8(16):27199-27215. PubMed ID: 28423712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
    Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
    Sharma P; Kumar S
    Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PlGF signaling and macrophage repolarization contribute to the anti-neoplastic effect of metformin.
    Ma Q; Gu JT; Wang B; Feng J; Yang L; Kang XW; Duan P; Sun X; Liu PJ; Wang JC
    Eur J Pharmacol; 2019 Nov; 863():172696. PubMed ID: 31562866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
    Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
    Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity.
    Leuci V; Maione F; Rotolo R; Giraudo E; Sassi F; Migliardi G; Todorovic M; Gammaitoni L; Mesiano G; Giraudo L; Luraghi P; Leone F; Bussolino F; Grignani G; Aglietta M; Trusolino L; Bertotti A; Sangiolo D
    J Transl Med; 2016 May; 14(1):119. PubMed ID: 27149858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.
    Davies G; Lobanova L; Dawicki W; Groot G; Gordon JR; Bowen M; Harkness T; Arnason T
    PLoS One; 2017; 12(12):e0187191. PubMed ID: 29211738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.